Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Research Papers
Bio/Technology  8, 945 - 949 (1990)
doi:10.1038/nbt1090-945

Removal of a Proteolytic Activity Associated with Aggregates Formed from Expression of Creatine Kinase in Escherichia coli Leads to Improved Recovery of Active Enzyme

Patricia C. Babbitt1, *, Brian L. West2, Douglas D. Buechter1, Irwin D. Kuntz1 & George L. Kenyon1

  1Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143.

  2Metabolic Research Unit, University of California, San Francisco, CA 94143.

  *Corresponding author.

Expression of creatine kinase (CK) from a Torpedo californica electric organ cDNA in Escherichia coli results in an insoluble protein product with no detectable CK activity. Although this is a stable aggregate that can be isolated in an enriched form by centrifugation, initial attempts to generate enzyme activity by denaturing and refolding yielded only minute amounts of active protein. We find that these low recoveries are due to proteolysis of the CK during denaturation and refolding. While this proteolytic activity is not inhibited by either phenylmethanesulfonyl fluoride (PMSF) or EDTA, it can be largely removed from the CK aggregate by extraction with a detergent-containing buffer prior to denaturation. This treatment improves the recovery of active CK approximately 100-fold. We have also found similar proteolytic activity associated with the aggregate formed when a mutant of bovine pancreatic trypsin inhibitor (BPTI) is expressed in E. coli. Discovery of this proteolytic activity in two different expression systems suggests that it should be considered as a potential problem for recovery of active protein from other inclusion bodies as well.

REFERENCES
  1. West, B.L., Babbitt, P.C., Mendez, B. and Baxter, J.D. 1984. Creatine kinase protein sequence encoded by a cDNA made from Torpedo californica electric organ mRNA. Proc. Natl. Acad. Sci. USA. 81: 7007−7011. | PubMed  | ChemPort |
  2. Weir, M.P. and Sparks, J. 1987. Purification and renaturation of recombinant human interleukin-2. Biochem. J. 245: 5−91.
  3. Sharma, S.K., Evans, D.B., Tomich, C.-S.C., Cornette, J.C. and Ulrich, R.G. 1987. Folding and activation of recombinant human prorenin. Biotech. Appld. Biochem. 9: 181−193. | ChemPort |
  4. Mitraki, A. and King, J. 1989. Protein folding intermediates and inclusion body formation. Bio/Technology 7: 690−697. | ISI | ChemPort |
  5. Marston, F.A.O. 1986. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J. 240: 1−12. | PubMed  | ISI | ChemPort |
  6. Schein, C.H. 1990. Solubility as a function of protein structure and solvent components. Bio/Technology 8: 308−317. | PubMed  | ISI | ChemPort |
  7. Schein, C.H. 1989. Production of soluble recombinant proteins in bacteria. Bio/Technology 7: 1141−1149. | ISI | ChemPort |
  8. Marston, F.A.O. 1987. The purification of eukaryotic polypeptides expressed in Escherichia coli 59−88. In: DNA Cloning: a Practical Approach (Vol. 3). Glover, D.M. (Ed.). IRL Press, Oxford, United Kingdom.
  9. Lim, W.K., Smith-Somerville, H.E. and Hardman, J.K. 1989. Solubilization and renaturation of overexpressed aggregates of mutant tryptophan synthase alpha-subunits. Appl. Environ. Microbiol. 55: 1106−1111. | PubMed  | ISI | ChemPort |
  10. Hoess, A., Arthur, A.K., Wanner, G. and Fanning, E. 1988. Recovery of soluble, biologically active recombinant proteins from total bacterial lysates using ion exchange resins. Bio/Technology 6: 1214−1217. | ISI | ChemPort |
  11. Bolyard, M.G. and Lord, S.T. 1988. High-level expression of a functional human fibrinogen gamma chain in Escherichia coli. Gene 66: 183−192. | Article | PubMed  | ISI | ChemPort |
  12. Nagai, K. and Thøgerson, H.C. Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli. Meth. in Enzymol. 153: 461−481. | ChemPort |
  13. Altman, J., Nilsson, B., Anderson, S. and Kuntz, I.D. 1990. Manuscript in preparation.
  14. Babbitt, P.C., West, B.L., Kuntz, I.D. and Kenyon, G.L. 1988. Purification of the insoluble aggregate obtained from the expression of creatine kinase in E. coli yields greatly improved specific activity in the refolded protein. Biochem. 27: 3093. | ISI |
  15. Holmes, D.S. and Quigley, M. 1981. A rapid boiling method for the preparation of bacterial plasmids. Anal. Biochem. 114: 193−197. | PubMed  | ISI | ChemPort |
  16. Hartley, D.L. and Kane, J.F. 1988. Properties of inclusion bodies from recombinant Escherichia coli. Biochem. Soc. Trans. 16: 101−102. | PubMed  | ISI | ChemPort |
  17. Babbitt, P.C., West, B.L., Buechter, D.D., Chen, L.H., Kuntz, I.D. and Kenyon, G.L. Recovery of active creatine kinase refolded from inclusion bodies in Escherichia coli can be improved by removal of a contaminating protease. In: Protein Refolding. Georgiou, G. (Ed.). American Chemical Society, New York. In press.
  18. Amann, E., Brosius, J. and Ptashne, M. 1983. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 25: 167−178. | PubMed  | ISI | ChemPort |
  19. Meselson, M. and Yuan, R. 1968. DNA restriction enzyme from E. coli. Nature 217: 1110−1114. | PubMed  | ISI | ChemPort |
  20. Grossman, S.H., Pyle, J. and Steiner, R.J. 1981. Kinetic evidence for active monomers during the reassembly of denatured creatine kinase. Biochem. 20: 6122−6128. | ISI | ChemPort |
  21. Creighton, T.E. and Goldenberg, D.P. 1984. Folding pathway of a circular form of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 179: 497−526. | PubMed  | ISI | ChemPort |
  22. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265−275. | PubMed  | ISI | ChemPort |
  23. Bradford, M.M. 1976. A rapid and sensitive method for the quantita-tion of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Chem. 72: 248−254. | Article | ChemPort |
  24. Tanzer, M.L. and Gilvarg, C.J. 1959. Creatine and creatine kinase measurement. J. Biol. Chem. 234: 3201−3204. | PubMed  | ISI | ChemPort |
  25. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680−685. | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1990 Nature Publishing Group | Privacy policy